SAbR For Oligo-Progressive Renal Cell Cancer.

NCT03696277 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Oligoprogressive Renal Cell Carcinoma

Interventions

RADIATION: Stereotactic ablative body radiation (SABR)

Sponsor

University of Texas Southwestern Medical Center